Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Minority HIV/AIDS Research Initiative (MARI) To Build Capacity in Black and Hispanic Communities and Among Black and Hispanic Researchers To Conduct HIV/AIDS Epidemiologic and Prevention Research, Funding Opportunity Announcement (FOA), PS11-003, Initial Review, 367-368 [2010-33124]

Download as PDF Federal Register / Vol. 76, No. 2 / Tuesday, January 4, 2011 / Notices Authority: Section 1420 of the Safe Drinking Water Act, as amended (1996), and 40 CFR Part 142 of the National Primary Drinking Water Regulations. Dated: December 22, 2010. Dennis J. McLerran, Regional Administrator, Region 10. [FR Doc. 2010–33192 Filed 1–3–11; 8:45 am] BILLING CODE 6560–50–P DEPARTMENT OF HEALTH AND HUMAN SERVICES (HHS) Centers for Disease Control and Prevention (CDC) Office of State, Tribal, Local and Territorial Support (OSTLTS) jlentini on DSKJ8SOYB1PROD with NOTICES In accordance with Presidential Executive Order No. 13175, November 6, 2000, and the Presidential Memorandum of November 5, 2009 and September 23, 2004, Consultation and Coordination with Indian Tribal Governments, CDC, OSTLTS announces the following meeting and Tribal Consultation Session: Name: Tribal Consultation Advisory Committee (TCAC) Meeting and 6th Biannual Tribal Consultation Session Times and Dates: 8:30 a.m.–5 p.m., February 1–2, 2011 (TCAC Meeting) 8:30 a.m.–5 p.m., February 3, 2011 (6th Biannual Tribal Consultation Session) Place: CDC, 1600 Clifton Road, NE., Building 21, Atlanta, Georgia 30333. Status: The TCAC meeting is open to the public. Attendance at the Tribal Consultation meeting is by special invitation to the American Indian/Alaska Native (AI/AN) Tribal Leaders from across the nation. Visitors must be processed in accordance with established federal policies and procedures. All visitors are required to present a valid form of picture identification issued by a state or federal government. The meeting room accommodates approximately 100 people. Purpose: CDC released their Tribal Consultation Policy in October of 2005 with the primary purpose of providing guidance across the agency to work effectively with AI/ AN tribes, communities, and organizations to enhance AI/AN access to CDC resources and programs. In November of 2006, an Agency Advisory Committee (CDC/Agency for Toxic Substances and Disease Registry Tribal Consultation Advisory Committee—TCAC) was established to provide a complementary venue wherein tribal representatives and CDC staff have the opportunity to exchange information about public health issues in Indian Country, identifying urgent public health needs in AI/AN communities, and discuss collaborative approaches to these issues and needs. Within the CDC Consultation Policy, it is stated that CDC will conduct government-to-government consultation with elected tribal officials or VerDate Mar<15>2010 14:35 Jan 03, 2011 Jkt 223001 their designated representatives and also confer with AI/AN organizations and AI/AN urban and rural communities before taking actions and or making decisions that affect them. Consultation is designed to be an enhanced form of communication that emphasizes trust, respect, and shared responsibility. It is an open and free exchange of information and opinion among parties that leads to mutual understanding and comprehension. CDC believes that consultation is integral to a deliberative process that results in effective collaboration and informed decision making with the ultimate goal of reaching consensus on issues. Although formal responsibility for the agency’s overall government-to-government consultation activities rests within the OSTLTS, leadership of other CDC Centers, Institutes and Offices shall actively participate in TCAC meetings and HHSsponsored regional and national tribal consultation sessions as frequently as possible. Matters to be Discussed: The TCAC will convene their advisory committee meeting with discussions and presentations by various CDC senior leaders on activities and areas identified by TCAC members and other tribal leaders as priority public health issues. The Biannual Tribal Consultation Session will engage CDC Senior leadership from the Office of the Director and various CDC Centers, Institutes and Offices. Opportunities will be provided during the consultation session for tribal testimony. Tribal Leaders are encouraged to submit written testimony by close of business on January 15, 2011, to the contact person listed below. It may be necessary to limit the time of each presenter due to the availability of time. The agenda is subject to change as priorities dictate. Information on previous TCAC and Tribal Consultation meetings is available at web link https://www.cdc.gov/ostlts/ tribal_public_health/. Contact Person for More Information: Kimberly Cantrell, Senior Tribal Liaison for Policy and Evaluation, OSTLTS, CDC, 4770 Buford Highway, MS E–19, Atlanta, Georgia 30341, telephone (404) 498–0411, e-mail: KLW6@cdc.gov. The Director, Management Analysis and Services Office has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention, and the Agency for Toxic Substances and Disease Registry. Dated: December 27, 2010. Andre Tyler, Acting Director, Management Analysis and Services Office Centers for Disease Control and Prevention. [FR Doc. 2010–33126 Filed 1–3–11; 8:45 am] BILLING CODE 4163–18–P PO 00000 Frm 00056 Fmt 4703 Sfmt 4703 367 DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Minority HIV/ AIDS Research Initiative (MARI) To Build Capacity in Black and Hispanic Communities and Among Black and Hispanic Researchers To Conduct HIV/ AIDS Epidemiologic and Prevention Research, Funding Opportunity Announcement (FOA), PS11–003, Initial Review In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting: Times and Dates: 8 a.m.–5 p.m., March 14, 2011 (Closed) 8 a.m.–5 p.m., March 15, 2011 (Closed) Place: Sheraton Gateway Hotel Atlanta Airport, 1900 Sullivan Road, Atlanta, Georgia 30337, Telephone: (770)997–1100. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92– 463. Matters to be Discussed: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘Minority HIV/AIDS Research Initiative (MARI) to Build Capacity in Black and Hispanic Communities and Among Black and Hispanic Researchers to Conduct HIV/AIDS Epidemiologic and Prevention Research, FOA PS11–003, initial review.’’ Contact Person for More Information: Amy Yang, Ph.D., Scientific Review Officer, CDC, 1600 Clifton Road, NE., Mailstop E60, Atlanta, Georgia 30333, Telephone: (404) 498–2733. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. E:\FR\FM\04JAN1.SGM 04JAN1 368 Federal Register / Vol. 76, No. 2 / Tuesday, January 4, 2011 / Notices Dated: December 20, 2010. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration Food and Drug Administration [FR Doc. 2010–33124 Filed 1–3–11; 8:45 am] [Docket No. FDA–2010–N–0374] [Docket No. FDA–2010–N–0373] Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Petition To Request an Exemption From 100 Percent Identity Testing of Dietary Ingredients; Current Good Manufacturing Practice in Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Preparing a Claim of Categorical Exclusion or an Environmental Assessment for Submission to the Center for Food Safety and Applied Nutrition BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA–2009–N–0296] Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Food Labeling Regulations AGENCY: Food and Drug Administration, HHS. ACTION: Food and Drug Administration, HHS. ACTION: Notice. The Food and Drug Administration (FDA) is announcing that a collection of information entitled ‘‘Food Labeling Regulations’’ has been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995. FOR FURTHER INFORMATION CONTACT: Denver Presley, Jr., Office of Information Management, Food and Drug Administration, 1350 Piccard Dr., PI50– 400B, Rockville, MD 20850, 301–796– 3793. In the Federal Register of July 15, 2010 (75 FR 41207), the Agency announced that the proposed information collection had been submitted to OMB for review and clearance under 44 U.S.C. 3507. An Agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. OMB has now approved the information collection and has assigned OMB control number 0910–0381. The approval expires on December 31, 2013. A copy of the supporting statement for this information collection is available on the Internet at https:// www.reginfo.gov/public/do/PRAMain. SUPPLEMENTARY INFORMATION: Dated: December 27, 2010. David Dorsey, Acting Deputy Commissioner for Policy, Planning and Budget. [FR Doc. 2010–33212 Filed 1–3–11; 8:45 am] BILLING CODE 4160–01–P Food and Drug Administration, HHS. ACTION: Notice. The Food and Drug Administration (FDA) is announcing that a collection of information entitled ‘‘Preparing a Claim of Categorical Exclusion or an Environmental Assessment for Submission to the Center for Food Safety and Applied Nutrition’’ has been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995. SUMMARY: The Food and Drug Administration (FDA) is announcing that a collection of information entitled ‘‘Petition to Request an Exemption From 100 Percent Identity Testing of Dietary Ingredients; Current Good Manufacturing Practice in Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements’’ has been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995. SUMMARY: Notice. SUMMARY: jlentini on DSKJ8SOYB1PROD with NOTICES AGENCY: AGENCY: FOR FURTHER INFORMATION CONTACT: Denver Presley, Jr., Office of Information Management, Food and Drug Administration, 1350 Piccard Dr., PI50– 400B, Rockville, MD 20850, 301–796– 3793. In the Federal Register of September 30, 2010 (75 FR 60463), the Agency announced that the proposed information collection had been submitted to OMB for review and clearance under 44 U.S.C. 3507. An Agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. OMB has now approved the information collection and has assigned OMB control number 0910–0608. The approval expires on December 31, 2013. A copy of the supporting statement for this information collection is available on the Internet at https:// www.reginfo.gov/public/do/PRAMain. SUPPLEMENTARY INFORMATION: Dated: December 27, 2010. David Dorsey, Acting Deputy Commissioner for Policy, Planning and Budget. FOR FURTHER INFORMATION CONTACT: Denver Presley, Jr., Office of Information Management, Food and Drug Administration, 1350 Piccard Dr., PI50– 400B, Rockville, MD 20850. 301–796– 3793. In the Federal Register of September 28, 2010 (75 FR 59722), the Agency announced that the proposed information collection had been submitted to OMB for review and clearance under 44 U.S.C. 3507. An Agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. OMB has now approved the information collection and has assigned OMB control number 0910–0541. The approval expires on December 31, 2013. A copy of the supporting statement for this information collection is available on the Internet at https:// www.reginfo.gov/public/do/PRAMain. SUPPLEMENTARY INFORMATION: Dated: December 27, 2010. David Dorsey, Acting Deputy Commissioner for Policy, Planning and Budget. [FR Doc. 2010–33210 Filed 1–3–11; 8:45 am] BILLING CODE 4160–01–P [FR Doc. 2010–33209 Filed 1–3–11; 8:45 am] BILLING CODE 4160–01–P VerDate Mar<15>2010 14:35 Jan 03, 2011 Jkt 223001 PO 00000 Frm 00057 Fmt 4703 Sfmt 9990 E:\FR\FM\04JAN1.SGM 04JAN1

Agencies

[Federal Register Volume 76, Number 2 (Tuesday, January 4, 2011)]
[Notices]
[Pages 367-368]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-33124]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Minority HIV/AIDS Research Initiative (MARI) To 
Build Capacity in Black and Hispanic Communities and Among Black and 
Hispanic Researchers To Conduct HIV/AIDS Epidemiologic and Prevention 
Research, Funding Opportunity Announcement (FOA), PS11-003, Initial 
Review

    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the aforementioned meeting:

    Times and Dates:
    8 a.m.-5 p.m., March 14, 2011 (Closed)
    8 a.m.-5 p.m., March 15, 2011 (Closed)

    Place: Sheraton Gateway Hotel Atlanta Airport, 1900 Sullivan Road, 
Atlanta, Georgia 30337, Telephone: (770)997-1100.
    Status: The meeting will be closed to the public in accordance with 
provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., 
and the Determination of the Director, Management Analysis and Services 
Office, CDC, pursuant to Public Law 92-463.
    Matters to be Discussed: The meeting will include the initial 
review, discussion, and evaluation of applications received in response 
to ``Minority HIV/AIDS Research Initiative (MARI) to Build Capacity in 
Black and Hispanic Communities and Among Black and Hispanic Researchers 
to Conduct HIV/AIDS Epidemiologic and Prevention Research, FOA PS11-
003, initial review.''
    Contact Person for More Information: Amy Yang, Ph.D., Scientific 
Review Officer, CDC, 1600 Clifton Road, NE., Mailstop E60, Atlanta, 
Georgia 30333, Telephone: (404) 498-2733. The Director, Management 
Analysis and Services Office, has been delegated the authority to sign 
Federal Register notices pertaining to announcements of meetings and 
other committee management activities, for both the Centers for Disease 
Control and Prevention and the Agency for Toxic Substances and Disease 
Registry.


[[Page 368]]


    Dated: December 20, 2010.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2010-33124 Filed 1-3-11; 8:45 am]
BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.